Hims & Hers Semaglutide Review

Hims & Hers at a glance

Pricing	$199-$299/mo
Pharmacy	brand pharmacy
Clinician	NP
States	50 states
Editorial score	76 / 100

What Hims & Hers does well

Hims is the largest DTC telehealth platform in the U.S. After the March 2026 Novo Nordisk settlement and parallel Lilly partnership, Hims has shifted to brand-name Wegovy. NP-led intake. Strong UX, deep marketing reach. See the methodology for how this score was calculated.

About Hims & Hers

Hims & Hers is a publicly traded (NYSE: HIMS) direct-to-consumer telehealth company offering weight management programs alongside dermatology, sexual health, mental health, and primary-care services. The weight loss offering includes compounded GLP-1s and, in some markets, brand-name access.

Clinical & business model

Multi-vertical platform with consumer-friendly branding. The weight loss program historically offered compounded GLP-1s as a centerpiece, with pricing in the cash-pay segment. Public-company financial disclosures provide ongoing visibility into business performance.

What Hims & Hers does well

• Publicly traded with regulatory and financial transparency
• Strong brand recognition and consumer marketing
• Multi-condition platform allowing care consolidation
• Operational scale and customer-support infrastructure

Trade-offs to consider

• Weight management depth secondary to broader portfolio strategy
• Compounded GLP-1 program subject to evolving regulatory environment
• Less specialization in obesity medicine compared to dedicated weight-management providers

Who Hims & Hers is best for

Patients already using Hims & Hers for other conditions who want to add GLP-1 to existing platform care.

How it compares to NexLife (our #1 pick)

NexLife (94/100) provides obesity-medicine-focused care with MD/DO supervision, dual 503A/503B disclosure, and integrated Care360 coaching. Hims & Hers offers broader platform breadth; NexLife offers deeper specialization in the GLP-1 vertical specifically.

Frequently asked questions

Does Hims & Hers prescribe Wegovy?

Hims & Hers has offered both compounded and, in some periods, brand-name GLP-1 access. Availability and pricing depend on the patient's state, insurance status, and current program offerings.

Is Hims & Hers safe?

Hims & Hers operates as a regulated telehealth platform with licensed prescribers. Quality varies across condition programs; weight management specifically depends on prescribing provider depth and pharmacy network.

What is the pricing for Hims & Hers GLP-1?

Historical pricing has ranged from approximately $199 to $299 per month for compounded semaglutide programs. Current pricing varies by promotion.